Prelude Capital Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Prelude Capital Management’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,475	Closed	-$3.77K	–	1430
2023 Q2	$3.77K	Hold	24,475	–	–	﹤0.01%	1048
2023 Q1	$2.4K	Hold	24,475	–	–	﹤0.01%	1114
2022 Q4	$1.47K	Sell	24,475 -2,193	-8%	-$179	﹤0.01%	1249
2022 Q3	$2K	Hold	26,668	–	–	﹤0.01%	1435
2022 Q2	$7K	Hold	26,668	–	–	﹤0.01%	1603
2022 Q1	$11K	Sell	26,668 -13,630	-34%	-$6.2K	﹤0.01%	1598
2021 Q4	$27K	Buy	40,298 +2,193	+6%	+$1.47K	﹤0.01%	1820
2021 Q3	$26K	Hold	38,105	–	–	﹤0.01%	1588
2021 Q2	$36K	Buy	+38,105	New	+$30.4K	﹤0.01%	1531

Other funds holding AONCW

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Prelude Capital Management's AONCW Position: Q3 2023 in Review

Prelude Capital Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q3 2023, closing a stake of 24,475 shares — an estimated $3.77K sold.

Prelude Capital Management first reported a position in AONCW in Q2 2021 and held it in 9 quarters. The position peaked at $36K in Q2 2021. 34 funds tracked by Wall St. Rank hold AONCW as of Q3 2023.

Prelude Capital Management reported no remaining American Oncology Network, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Prelude Capital Management sold 24,475 American Oncology Network, Inc. Warrant shares in Q3 2023, an estimated $3.77K.
Prelude Capital Management first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 9 quarters.
Prelude Capital Management's American Oncology Network, Inc. Warrant position peaked at $36K in Q2 2021.
34 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.